CN Patent

CN111093668A — Gsk1278863 的晶型及其制备方法和制药用途

Assigned to GlaxoSmithKline Intellectual Property No 2 Ltd · Expires 2020-05-01 · 6y expired

What this patent protects

一种缺氧诱导因子脯氨酰羟化酶抑制剂化合物(I)GSK1278863的晶型CS1和CS9，及其制备方法和其在制备用于治疗和/或预防贫血的药物制剂中的用途。

USPTO Abstract

一种缺氧诱导因子脯氨酰羟化酶抑制剂化合物(I)GSK1278863的晶型CS1和CS9，及其制备方法和其在制备用于治疗和/或预防贫血的药物制剂中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN111093668A
Jurisdiction
CN
Classification
—
Expires
2020-05-01
Drug substance claim
No
Drug product claim
No
Assignee
GlaxoSmithKline Intellectual Property No 2 Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.